Cytoimage Inc.

Portland, OR · Founded 2020 · CIK 0001872229 · Medtech · Private

Imaging platform with super-localization algorithms for single-cell protein detection and drug combination screening

cytoimageinc.com →
Grants
$450K
2 awards
Sector median: 1
Raised
$225K
1 Form D · Jul 2021
63 months since last filing
Contracts
$150K
1 award · Health and Human S
#489 of 4531 in medtech
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal contractDepartment of Health and Human Services · SBIR Phase I Igf::ot::igf$149,531
Federal grantDepartment of Health and Human Services · Phase I · Single Cell CytoScreen: An Imaging Platform for Evaluating Drug Combination Efficacy and Resistance in Individual Cancer Patients$300,000
Private capital raisedForm D · SEC$225,000
Federal grant · SBIR/STTRFederal contract · USAspendingForm D · SEC

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
486Transient Electronics Inc.$150K—
487SOFTSONICS LLC$150K—
488Perfuzia Medical$150K—
489Cytoimage Inc.$150K$225K
490CANTON BIOTECHNOLOGIES, INC.$149K—
491Awarables, Inc.$149K$500K
492CND LIFE SCIENCES, INC.$146K$19M

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

From Form D filings · 4 related persons
  • Ann BunnenbergDirector · Executive Officer
  • Sandra ShotwellDirector
  • Lynnor StevensonDirector · Executive Officer
  • Tania VuDirector · Executive Officer

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.